sulfamethoxypyridazine has been researched along with resorcinol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Dong, L; Liu, A; Liu, ZQ; Wei, XL; Xiao, JH; Yang, XH | 1 |
2 other study(ies) available for sulfamethoxypyridazine and resorcinol
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Development of amino- and dimethylcarbamate-substituted resorcinol as programmed cell death-1 (PD-1) inhibitor.
Topics: Amino Acids; Antineoplastic Agents; Drug Design; Molecular Structure; Optical Imaging; Programmed Cell Death 1 Receptor; Resorcinols; Structure-Activity Relationship; Sulfamethizole; Sulfamethoxypyridazine | 2016 |